Invesco’s Nobilis Health Corp. HLTH Stock Holding History

Invesco’s Portfolio HLTH Stock Details HLTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-31,615	Closed	-$99K	–	3753
2016 Q1	$99K	Sell	31,615 -2,221	-7%	-$5.74K	﹤0.01%	3643
2015 Q4	$95K	Buy	33,836 +1,285	+4%	+$4.11K	﹤0.01%	3660
2015 Q3	$170K	Sell	32,551 -1,004	-3%	-$5.76K	﹤0.01%	3615
2015 Q2	$228K	Buy	+33,555	New	+$238K	﹤0.01%	3682

Other funds holding HLTH

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

SCA

Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MCM

McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco's HLTH Position: Q2 2016 in Review

Invesco sold out of Nobilis Health Corp. (HLTH) in Q2 2016, closing a stake of 31,615 shares — an estimated $99K sold.

Invesco first reported a position in HLTH in Q2 2015 and held it in 4 quarters. The position peaked at $228K in Q2 2015. 67 funds tracked by Wall St. Rank hold HLTH as of Q2 2016.

Invesco reported no remaining Nobilis Health Corp. position as of Q2 2016 after selling out during the quarter.
Invesco sold 31,615 Nobilis Health Corp. shares in Q2 2016, an estimated $99K.
Invesco first reported a position in Nobilis Health Corp. in Q2 2015 and held it in 4 quarters.
Invesco's Nobilis Health Corp. position peaked at $228K in Q2 2015.
67 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q2 2016.

Based on Invesco's 13F filing for Q2 2016, filed 15 Aug 2016.